Author: Deborggraeve, Stijn; Laurent, Thierry; Espinosa, Diego; Van der Auwera, Gert; Mbuchi, Margaret; Wasunna, Monique; El-Safi, Sayda; Al-Basheer, Ahmed Almustafa; Arévalo, Jorge; Miranda-Verástegui, César; Leclipteux, Thierry; Mertens, Pascal; Dujardin, Jean-Claude; Herdewijn, Piet; Büscher, Philippe
Title: A Simplified and Standardized Polymerase Chain Reaction Format for the Diagnosis of Leishmaniasis Cord-id: ohfhnpma Document date: 2008_11_15
ID: ohfhnpma
Snippet: Background. Definite diagnosis of Leishmania infections is based on demonstration of the parasite by microscopic analysis of tissue biopsy specimens or aspirate samples. However, microscopy generally shows low sensitivity and requires invasive sampling. Methods. We describe here the development of a simple and rapid test for the detection of polymerase chain reaction-amplified Leishmania DNA. A phase 1 evaluation of the text was conducted in clinical samples from 60 nonendemic and 45 endemic con
Document: Background. Definite diagnosis of Leishmania infections is based on demonstration of the parasite by microscopic analysis of tissue biopsy specimens or aspirate samples. However, microscopy generally shows low sensitivity and requires invasive sampling. Methods. We describe here the development of a simple and rapid test for the detection of polymerase chain reaction-amplified Leishmania DNA. A phase 1 evaluation of the text was conducted in clinical samples from 60 nonendemic and 45 endemic control subjects and from 44 patients with confirmed cutaneous leishmaniasis (CL), 12 with mucocutaneous leishmaniasis (MCL), and 43 with visceral leishmaniasis (VL) from Peru, Kenya, and Sudan. Results. The lower detection limits of the assay are 10 fg of Leishmania DNA and 1 parasite in 180 µL of blood. The specificity was 98.3% (95% confidence interval [CI], 91.1%–99.7%) and 95.6% (95% CI, 85.2%–98.8%) for nonendemic and endemic control samples, respectively, and the sensitivity was 93.2% (95% CI, 81.8%–97.7%), 91.7% (95% CI, 64.6%–98.5%), and 86% (95% CI, 72.7%–93.4%) for lesions from patients with CL or MCL and blood from patients with VL, respectively. Conclusions. The Leishmania OligoC-TesT showed high specificity and sensitivity in clinical samples and was able to detect the parasite in samples obtained by less invasive means, such as blood, lymph, and lesion scrapings. The assay is a promising new tool for simplified and standardized molecular detection of Leishmania parasites.
Search related documents:
Co phrase search for related documents- accession number and low number: 1
- accurate detection and acid amplification technique: 1
- accurate detection and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- accurate detection and additional pcr: 1
- accurate detection and low number: 1, 2, 3
- accurate detection and low sensitivity: 1, 2, 3, 4, 5, 6
- accurate molecular diagnosis and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- accurate molecular diagnosis and low number: 1
- acid amplification technique and acute respiratory syndrome: 1
- acid amplification technique and low sensitivity: 1
- acid stain and acute respiratory syndrome: 1, 2
- acid stain and low sensitivity: 1
- active edge and acute respiratory syndrome: 1
- acute respiratory syndrome and additional pcr: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- acute respiratory syndrome and low assay detection limit: 1
- acute respiratory syndrome and low number: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory syndrome and low sensitivity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- additional pcr and low number: 1, 2
- additional pcr and low sensitivity: 1
Co phrase search for related documents, hyperlinks ordered by date